España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
CNBC
Jim Cramer Recommends Buying Ethereum Or Bitcoin Instead Of This Stock: 'Let's Not Fool Around'
American Express, Interactive Brokers And More On CNBC's 'Final Trades'
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
American Express, Interactive Brokers And More On CNBC's 'Final Trades'
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
Shell, Freeport-McMoRan, Steel Dynamics And More On CNBC's 'Final Trades'
Amgen, Shell And More On CNBC's 'Final Trades'
Shell, Freeport-McMoRan, Steel Dynamics And More On CNBC's 'Final Trades'
Amgen, Shell And More On CNBC's 'Final Trades'
Chevron, Chubb, Toast And More On CNBC's 'Final Trades'
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer
Read More...
CNBC Recent News
Applied Materials, BHP Group, Allstate And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named U.S.
Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE: HZO).
Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic (NYSE: MDT). "I like what they’re doing in AI.
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Nasdaq, Inc. (NASDAQ: NDAQ) is
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over
Uber, Aptiv And A Major Airline Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Delta Air Lines, Inc. (NYSE: DAL), which is scheduled to report quarterly earnings on Wednesday.
Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ: AMZN) is on the
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).
Jim Cramer: 'Nothing Terrific' About GitLab, But Rocket? Time To 'Ka-Ching, Ka-Ching'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he didn’t like the last quarter of GitLab Inc. (NASDAQ: GTLB). "I went over it with a fine tooth comb.
Meta, Charles Schwab, Booking Holdings And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young, SoFi head of investment strategy, picked VanEck Gold Miners ETF (NYSE: GDX), saying the commodity is
Thermo Fisher Scientific, GXO Logistics And A Financial Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners picked GXO Logistics, Inc.
Schlumberger, Transocean And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management picked North Shore Global Uranium Mining ETF (NYSE: URNM).
Wynn Resorts, Hilton Worldwide And An Energy Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Wynn Resorts, Limited (NASDAQ: WYNN)
Jim Cramer Says 'Ka-Ching' For This Airline Stock, Plus: 'Ring The Register' For Kodiak
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Tyler Technologies, Inc. (NYSE: TYL).
Berkshire Hathaway And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Cerity Partners' Jim Lebenthal picked Berkshire Hathaway Inc. (NYSE: BRK-B) (NYSE:
Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Core & Main, Inc. (NYSE: CNM) is "right at the heart of this infrastructure bull market I keep talking about because it does waste water.
Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'
CNBC’s Jim Cramer can’t recommend Archer Aviation Inc. (NYSE: ACHR).
Jim Cramer: Visa Is 'Too Close To All-Time High,' Chart Industries Is 'Absolutely Terrific'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Visa Inc. (NYSE: V) very much here and also likes that settlement that was announced on Tuesday. "The stock is too close to it’s all time high.
Target, Costco And A Major Healthcare Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said CVS Health Corporation (NYSE: CVS) came back strong on news about Amazon.com, Inc.
Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money'
On CNBC’s "Mad Money Lightning Round," Jim Cramer sang the praises of Energy Transfer LP (NYSE: ET), which posted better-than-expected earnings
Deere, ASML, Steel Dynamics And A Real Estate Stock: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said if you are looking for a stock that’s on the verge of
Boeing, Nvidia, PG&E And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said he bought a little The Boeing Company (NYSE:
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer.